Professional Documents
Culture Documents
DissolutionMulticomponentDrop Blood
DissolutionMulticomponentDrop Blood
PII S0301-5629(98)00034-9
Original Contribution
DISSOLUTION OF MULTICOMPONENT MICROBUBBLES IN THE
BLOODSTREAM: 1. THEORY
ALEXEY KABALNOV,* DAVID KLEIN, TIMOTHY PELURA, ERNEST SCHUTT and JEFFRY WEERS
Alliance Pharmaceutical Corporation, San Diego, CA
(Received 20 October 1997; in final form 2 March 1998)
AbstractThe problem of dissolution of a bubble in the bloodstream is examined. The bubble is assumed to be
filled with a mixture of a sparingly water-soluble gas (osmotic agent) and air. The dissolution of the bubble has
three definite stages. In Stage 1, the bubble quickly swells in air. The swelling ratio depends on the surface
tension, blood pressure, level of oxygen metabolism and initial mole fraction of osmotic agent in the bubble. In
Stage 2, the osmotic agent slowly diffuses out of the bubble. The squared radius decreases nearly linearly with
time, at a rate proportional to the Ostwald coefficient and diffusivity of the osmotic agent. In Stage 3, the partial
pressure of the osmotic agent becomes so high that it condenses into a liquid. In order to prolong the lifetime of
5-mm bubbles in the bloodstream from < 1 s (as found with pure air), the osmotic agent must have a low Ostwald
coefficient (< 1024) and a relatively high saturated vapor pressure at body temperature (> 0.3 atm 5 3 3 104
Pa). 1998 World Federation for Ultrasound in Medicine & Biology.
Key Words: Echocardiography, Ultrasound scattering, Ultrasound contrast media, Microbubbles, Microshells,
Microballoons, Ostwald coefficient, Dissolution kinetics, Molecular diffusion, Epstein-Plesset theory.
INTRODUCTION
gc 5
ks 2 km
3rs 2 3rm
; gd 5
km
2rs 1 rm
(1a)
(1)
740
dr
p# * 1 2 s /r 1
1
5 2DL
1
dt
p amt 1 4 s /3r r
p Dt
(2)
c water
.
C gas
Fig. 1. Dissolution of air bubble in the bloodstream, as predicted by eqn (2). s 5 70 mN/m; p# * 5 4300 Pa, r 0 5 2.5
m m; L and D values are those of nitrogen (Table 1).
Conversely, gases of low polarity, such as aliphatic hydrocarbons and fluorocarbons, prefer to stay in the vapor
phase and their Ostwald coefficients are much less than
unity.
From eqn (2), it is clear that microbubbles filled
with gases having smaller values of L will live longer.
Currently, several groups are exploring the development of microbubble ultrasound contrast agents in
which the microbubbles are filled with low Ostwald
coefficient gases (Bernstein et al. 1997; Correas and
Quay 1996; Kabalnov et al. 1995; Lohrmann 1996;
Mattrey et al. 1994; Porter et al. 1996; Quay 1995;
Schneider et al. 1995; Schutt et al. 1997; Unger et al.
1994). The Ostwald coefficient is not the only parameter controlling the microbubble stability, however.
The other important factor is the saturated vapor pressure of the osmotic agent at body temperature. If the
(3)
741
~C F 1 C A! RT 5 p A 1 p F 5
2s
1 p blood 1 p atm
r
(4)
JF 5 2
d 4p
~C Fr 3! 5 4 p rD F@c F~r! 2 c F~`!#
dt 3
(5)
d
~C r 3! 5 3rD FL FC F.
dt F
(6)
d
p atm
~C Fr 3! 5 3rD AL A C A 2
.
dt
RT
(7)
1
In the analysis, the nonsteady-state effects are neglected. The
time of establishing the steady state for diffusion from r 5 2.5-mm
particles has an order of r 2 /D ; 6 ms and is an insignificant correction
for the systems of interest.
742
m5
2s
p blood r
DA
;n5
; 5 r; d 5
;
p atmr 0
p atm r 0
DF
xA 5
C ART
C FRT
DF
; xF 5
; t 5 2 t;
p atm
p atm
r0
x Fr 3 5 F; and x Ar 3 5 A,
(8)
(9)
3L F
dF
52 2 F
dt
r
(10)
3dLA
dA
5 2 2 ~ A 2 r 3!.
dt
r
(11)
r ~0! 5 1
(12)
A~0! 1 F~0! 5 m 1 n 1 1
(13)
F~0!
5 X F.
A~0! 1 F~0!
(14)
743
Gas
Saturated
vapor
Boiling
Diffusion
Saturated vapor Saturated vapor concentration Water solubility
point
Molar volume
coefficient
pressure at 37C pressure at 25C (25C, mol/
of liquids
Ostwald coefficient
(C) (20C, cm3/mol) (D 3 10 9 , m2/s*)
(Pa)
(Pa)
m3)
(25C, mol/m3)
(L 3 10 6 )
N2
O2
C2F6
278.1
n-C4F10 22
n-C5F12
29
n-C6F14
59
105
153
177
201
19 (25C)
21 (25C)
8.6 (20C)
6.9 (20C)
6.3 (20C)
5.8 (20C)
3.5 3 106
3.8 3 105
1.3 3 105
4.8 3 104
2.8 3 106
2.6 3 105
8.5 3 104
2.9 3 104
1147
105.6
34.14
11.66
1.45
0.021
4 3 1023
2.7 3 1024
14480 (35C)
27730 (35C)
1272 (25C)
202 (25C)
117 (25C)
23 (25C)
* For oxygen and nitrogen, data from Lide (1991). For fluorocarbons, estimated from the molar volume with Hayduk-Laudie equation (Hayduk and
Laudie 1974). All the data refer to water as a solvent.
Reed (1964).
Kabalnov et al. (1990). For C2F6 and n-C4F10, approximation in the homologous series of linear perfluoroalkanes.
For oxygen and nitrogen, data from Wilhelm et al. (1977). For the other compounds, the ratio of the water and vapor concentrations, shown in
the previous two columns. The expected accuracy of L values is about one order of magnitude.
following section. The partial pressure of the osmotic agent increases with time, because it must
keep up with the increasing Laplace pressure inside
the shrinking bubble. During this stage, the squared
particle size decreases nearly linearly with time.
This stage contributes most to the overall bubble
lifetime.
(3) Eventually, the partial pressure of the osmotic agent
becomes high enough that it condenses into a liquid. The saturated vapor pressure of n-perfluorobutane at 37C equals 3.2 atm, and the condensation
of the bubble into liquid may occur anytime after
reaching this point (see the insert in Fig. 3A). After
condensation, the particle size and compressibility
exhibit a sharp drop and the particle becomes invisible to ultrasound. The nucleation of a new phase
may require supersaturation, and the exact moment
of the condensation is somewhat uncertain.
Figure 4 shows the effects of the interfacial tension and
the blood systemic pressure on the kinetics of the dissolution of an n-C4F10-filled bubble. The higher interfacial
tension and blood pressure, the shorter is the bubble
lifetime. Characteristically, these parameters mostly affect the ultimate swelling of the bubble at Stage 1, and
not the slope of the r2 vs. t lines. Figure 5 illustrates the
effect of the initial mole fraction of osmotic agent in the
bubble. The X F value also mostly affects the swelling of
the bubble and not the slope of the r2 vs. t lines: at high
values of X F , the bubble swells in air; at low values, it
shrinks.
Although the effect of condensation is not significant for C4F10, it becomes more important for longerchain perfluoroalkanes. Figure 6 shows that for
n-C6F14, the condensation may already occur at Stage
Fig. 4. Effect of interfacial tension and effective excess pressure on dissolution of n-C4F10-filled bubble at r 0 5 2.5 mm and
X F 5 1. (A) s 5 70 mN/m; p# * 5 10 4 Pa; (B) s 5 70 mN/m;
p# * 5 4300 Pa; (C) s 5 70 mN/m; p# * 5 0; (D) s 5 20 mN/m;
p# * 5 10 4 Pa; (E) s 5 20 mN/m; p# * 5 4300 Pa; (F) s 5 20
mN/m; p# * 5 0.
744
(15)
(17)
and
p F 5 p blood 1
2s
.
r
(18)
(19)
S D
dr
dt
21
1 2 r 1 3 jr 2
52
3L F 1 1 jr
(20)
t lifetime 5
1 ln~1 1 jr ! r 3 r 2
2 1
.
3L F
j2
j
2
(21)
(22)
r 20
r 2
3D FL F
(23)
1 2
r
3L F
t lifetime <
F 5 mr 2 1 nr 3.
745
2s
1 p blood 1 Dp O2 1 Dp CO2 1 Dp H2O
r
(24)
746
(25)
and
t lifetime 5
1 ln~1 1 j * r !
r
3 r 2
2
1
2
3L F
~ j *!
j*
2
(26)
The problem of dissolution of a bubble in the bloodstream has been considered. The bubble is assumed to
contain a sparingly water-soluble osmotic agent and air.
The dissolution of the bubble can be separated into three
definite stages:
In Stage 1, the bubble quickly swells or shrinks to a
new radius. The swelling ratio depends on the surface
tension s, the systemic blood pressure, the level of
oxygen metabolism and the initial mole fraction of the
osmotic agent in the bubble X F , The larger X F , and the
smaller p# * and s, the bigger is the swelling ratio r . The
functional relationship between them is determined by
eqn (25).
In Stage 2, the osmotic agent slowly diffuses from
the bubble. At this stage, the partial pressure of the
osmotic agent counterbalances the Laplace pressure, systemic blood pressure, as well as the oxygen, carbon
dioxide and water vapor difference pressures. The partial
pressure of osmotic agent increases as the radius of the
bubble decreases, to keep up with the increasing Laplace
pressure.
In Stage 3, the partial pressure of osmotic agent
becomes so high that the osmotic agent condenses. The
particle size and compressibility of the bubble exhibit a
sharp drop, and the bubble becomes invisible to ultrasound. The particle size at which the condensation occurs
(27)
747
(28)
748
p sat
.
RT
(29)
p* 5 p blood 1 Dp O 2 1
Dp CO 2 1 Dp H 2O Effective excess pressure
p# * Time-average effective
excess pressure
n * 5 p# */p atm
j * 5 n */ m
I Scattered intensity
I 0 Incident intensity
n Number density of
scattering particles
V Scattering volume
k Wave number
u Scattering angle
d Distance from scatterers
g c Compressibility term
g d Density term
k s , k m Compressibilities of the
scatterer and the medium,
respectively
r s , r m Densities of the scatterer
and the medium,
respectively
REFERENCES
Balen FG, Allen CM, Lees WR. Ultrasound contrast agents. Clin
Radiol 1994;49:77 82.
Bernstein H, Straub JA, Brush HT, Wing Richard E. Microencapsulated fluorinated gases for use as imaging agents. US Patent No.
5611344, 1997.
Burkard ME, Van Liew HD. Simulation of exchanges of multiple gases
in bubbles in the body. Resp Physiol 1994;95:131145.
Correas JM, Quay SD. EchoGen emulsion: A new ultrasound contrast
agent based on phase shift colloids. Clin Radiol 1996;51(Suppl.
1):1114.
Crank J. The Mathematics of Diffusion. Oxford; Clarendon Press,
1975.
de Jong N. Acoustic Properties of Ultrasound Contrast Agents, Ph.D.
thesis. Rotterdam, The Netherlands; Erasmus University, 1993.
Epstein PS., Plesset, MS. On the stability of gas bubbles in liquid-gas
solutions. J Chem Phys 1950;18:15051509.
Evans DF, Wennerstrom H. Colloidal domain. New York: VCH Publishers, 1994.
Fritzsch T, Schlief R. Future prospects for echo-enhancing agents. Clin
Radiol 1996;51(Suppl. 1):56 58.
Goldberg BB, Liu J-B, Forsberg F. Ultrasound contrast agents: A
review. Ultrasound Med Biol 1994;20:319.
Gramiak R, Shah PM. Echocardiography of the aortic root. Invest
Radiol 1968;3:356 366.
Hayduk W, Laudie H. Prediction of diffusion coefficients for nonelectrolytes in dilute aqueous solutions. AIChE J 1974;20:611 615.
Kabalnov AS, Pertsov AV, Shchukin ED. Ostwald ripening in twocomponent disperse phase systems: application to emulsion stability. Coll Surf 1987;24:19 32.
749
Kabalnov AS, Makarov KN, Shcherbakova OV. Solubility of fluorocarbon in water as a key parameter determining fluorocarbon emulsion stability. J Fluor Chem 1990;50:271284.
Kabalnov A, Weers JG, Schutt EA. Gas emulsions stabilized with
fluorinated ethers having low ostwald coefficients. US Patent Application No. 08/479,621, 1995.
Laughlin RG. The Aqueous Phase Behavior of Surfactants. San Diego:
Academic Press, 1996.
Lawson DD, Moacanin J, Scherer KV Jr, Terranova TF, Ingham JD.
Methods for the estimation of vapor properties and oxygen solubilities of fluorochemicals for possible application in artificial blood
formulations. J Fluor Chem 1978;12:221236.
Lide DR. CRC Handbook of Chemistry and Physics. Boca Raton: CRC
Press, 1991.
Lohrmann R. Gas-filled microspheres with fluorine-containing shells.
US Patent No 5562893, 1996.
Mattrey RF, Wrigley R, Steinbach GC, Schutt EG, Evitts DP. Gas
emulsions as ultrasound contrast agents: Preliminary results in
rabbits and dogs. Invest Radiol 1994;29;S139 S141.
Meltzer RS, Tickner EG, Popp RL. Why do the lungs clear ultrasonic
contrast? Ultrasound Med Biol 1980;6:263269.
Morse PM, Ingard, KU. Theoretical Acoustics. New York: McGraw
Hill, 1968.
PCR Research Chemicals Catalog. Gainesville, FL: PCR Inc., 1992.
Pison U, Herold R, Schurch S. The pulmonary surfactant system:
Biological functions, components, physico-chemical properties and
alterations during lung disease. Coll Surf A 1996;114:165184.
Porter TR, Xie F, Kricsfeld D, Armbruster RW. Improved myocardial
contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. J Am Coll Clin Cardiol 1996;27:1497
1501.
Quay SC. Methods for selecting and using gases as ultrasound contrast
media. US Patent No. 5,393,524, 1995.
Reed TM. Physical chemistry of fluorocarbons. In: Simons JH, ed.
Fluorine chemistry, vol. 5. New York: Academic Press, 1964:
.
Schlief R. Developments in echo-enhancing agents. Clin Radiol 1996;
51(Suppl. 1):57.
Schneider M, Yan F, Grenier P, Puginier J, Barrau, M-B. Long-lasting
aqueous dispersions or suspensions of pressure-resistant gas-filled
microvesicles and methods for preparation thereof. US Patent No.
5,413,774, 1995.
Schutt EA, Evitts DP, Kinner RA, Weers JG, Anderson CD. Stabilized
microbubble compositions for ultrasound. US Patent No. 5639443,
1997.
Unger EC, Matsunaga T, Ramaswami V, Yellowhair D, Wu G. Methods of preparing gas and gaseous precursor-filled microspheres.
International Patent Application No. PCT/US94/05792, 1994.
Van Liew HD, Burkard ME. Bubbles in circulating blood: Stabilization
and simulations of cyclic changes of size and content. J Appl
Physiol 1995a;79:1379 1385.
Van Liew HD, Burkard ME. Behavior of bubbles of slowly permeating
gas used for ultrasonic imaging contrast. Invest Radiol 1995b;30:
315321.
Wilhelm E, Battino R, Wilcock RJ. Low-pressure solubility of gases in
liquid water. Chem Rev 1977;77:219 262.
Yang W-J. Dynamics of gas bubbles in whole blood and plasma.
J Biomech 1971;4:119 125.